Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0820
+0.0020 (2.50%)
Sep 17, 2026, 3:56 PM AEST
Rhythm Biosciences Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 1.74 | 3.33 | 1.74 | - | - |
Other Revenue | - | - | - | 3.1 | 2.43 |
| 1.74 | 3.33 | 1.74 | 3.1 | 2.43 | |
Revenue Growth | -47.67% | 90.90% | -43.72% | 27.54% | 118.98% |
Cost of Revenue | 0.41 | 0.22 | 3.05 | - | - |
Gross Profit | 1.33 | 3.1 | -1.31 | 3.1 | 2.43 |
Selling, General & Admin | 5.95 | 5.12 | 3 | 7.7 | 5.99 |
Research & Development | 1.04 | 1.38 | 2.35 | 3.65 | 5.16 |
Amortization of Goodwill & Intangibles | - | - | - | 0.04 | 0.04 |
Operating Expenses | 7.18 | 6.7 | 5.55 | 11.54 | 11.25 |
Operating Income | -5.86 | -3.6 | -6.85 | -8.44 | -8.82 |
Interest Expense | -0.07 | -0.07 | -0 | -0.01 | - |
Interest & Investment Income | - | - | - | 0.23 | 0.02 |
EBT Excluding Unusual Items | -5.93 | -3.66 | -6.86 | -8.22 | -8.79 |
Merger & Restructuring Charges | - | -0.17 | - | - | - |
Pretax Income | -5.93 | -3.83 | -6.86 | -8.22 | -8.79 |
Net Income | -5.93 | -3.83 | -6.86 | -8.22 | -8.79 |
Net Income to Common | -5.93 | -3.83 | -6.86 | -8.22 | -8.79 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 334 | 269 | 228 | 217 | 210 |
Shares Outstanding (Diluted) | 334 | 269 | 228 | 217 | 210 |
Shares Change | 24.14% | 17.94% | 5.26% | 3.31% | 13.35% |
EPS (Basic) | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 |
EPS (Diluted) | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.26 | -2.94 | -6.22 | -7.06 | -6.52 |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 |
Gross Margin | 76.29% | 93.24% | -74.90% | 100.00% | 100.00% |
Operating Margin | -336.37% | -108.09% | -393.34% | -272.60% | -363.29% |
Profit Margin | -340.67% | -115.13% | -393.52% | -265.44% | -362.26% |
Free Cash Flow Margin | -302.10% | -88.52% | -356.94% | -227.94% | -268.74% |
EBITDA | -5.67 | -3.4 | -6.65 | -8.34 | -8.72 |
EBITDA Margin | - | -102.17% | - | -269.35% | - |
D&A For EBITDA | 0.19 | 0.2 | 0.2 | 0.1 | 0.09 |
EBIT | -5.86 | -3.6 | -6.85 | -8.44 | -8.82 |
EBIT Margin | - | -108.09% | - | -272.60% | - |